TY - JOUR
KW - naloxone
KW - prescribing patterns
KW - Race Factors -- United States
KW - Analgesics, Opioid
KW - Human
KW - Overdose
KW - Prescriptions, Drug
KW - Racism -- United States
KW - United States
KW - Chronic Pain
KW - Electronic Health Records
KW - Fractures
KW - Bone and Bones -- Injuries
KW - Multiple Logistic Regression
KW - Ethnic Groups
KW - Black Persons
KW - Native Americans
KW - Hispanic Americans
KW - Minority Groups
AU - Erin Fanning Madden
AU - Fares Qeadan
A1 - 
AD - Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA; Department of Family and Preventive Medicine, University of Utah, Salt Lake City, Utah, USA
BT - Substance Abuse
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 2
CY - Philadelphia, Pennsylvania
DO - 10.1080/08897077.2019.1686721
IS - 2
JF - Substance Abuse
LA - English
M1 - Journal Article
PB - Taylor & Francis Ltd
PP - Philadelphia, Pennsylvania
PY - 2020
SN - 0889-7077
SP - 232
EP - 244
EP - 
T1 - Racial inequities in U.S. naloxone prescriptions
T2 - Substance Abuse
TI - Racial inequities in U.S. naloxone prescriptions
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1080/08897077.2019.1686721
UR - https://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=142867039&site=ehost-live
VL - 41
VO - 0889-7077
Y1 - 2020
Y2 - 04
ER -